# Effect of Candesartan in Alcoholic Liver Fibrosis

> **NCT00990639** · PHASE1,PHASE2 · COMPLETED · sponsor: **Yonsei University** · enrollment: 85 (actual)

## Conditions studied

- Alcoholic Liver Disease

## Interventions

- **DRUG:** candesartan for hepatic fibrosis

## Key facts

- **NCT ID:** NCT00990639
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2008-12
- **Final completion:** 2009-03
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2009-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00990639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00990639, "Effect of Candesartan in Alcoholic Liver Fibrosis". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00990639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*